Physician Assistant, Medical · San Antonio, TX
NPI
1811367451
Since 2015
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3619 Paesanos Pkwy Ste 212
San Antonio, TX, 78231
Phone (210) 233-7000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$19.7M
4,605 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Tram Pham prescribed most often to Medicare patients was Xifaxan (Rifaximin), with 3,713 prescriptions and refills. In total Tram Pham wrote 4,605 Medicare prescriptions that cost $19.7M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Xifaxan Rifaximin | 3,713 | 3,886 | 642 | $12.0M |
| Vemlidy Tenofovir Alafenamide | 115 | 137 | 20 | $192K |
| Humira(Cf) Pen Adalimumab | 91 | 91 | 26 | $729K |
| Epclusa Sofosbuvir/Velpatasvir | 78 | 78 | 33 | $1.9M |
| Cosentyx Sensoready (2 Pens) Secukinumab | 61 | 61 | 18 | $435K |
| Dupixent Pen Dupilumab | 58 | 58 | 20 | $208K |
| Otezla Apremilast | 55 | 55 | 21 | $250K |
| Skyrizi Pen Risankizumab-Rzaa | 52 | 140 | 33 | $1.1M |
| Taltz Autoinjector Ixekizumab | 49 | 49 | 16 | $326K |
| Entecavir Generic | 37 | 77 | Under 11 | $3,522 |
| Rinvoq Upadacitinib | 33 | 33 | Under 11 | $217K |
| Enbrel Sureclick Etanercept | 28 | 32 | 12 | $230K |
| Stelara Ustekinumab | 25 | 50 | Under 11 | $573K |
| Kevzara Sarilumab | 22 | 22 | Under 11 | $89K |
| Tremfya Guselkumab | 19 | 35 | Under 11 | $241K |
Brand drugs: 4,543 claims; generic drugs: 62 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Tram Pham were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.